ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding

October 9, 1987

In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards

July 13, 1990

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012